05/02/2025 | Short News
This year, the dialysis center in Sokolov, Czech Republic, celebrates its 40th anniversary. Operating under the Fresenius Medical Care (FME) brand, NephroCare delivers comprehensive care to approximately 100 dialysis patients—from nephrological assessments to the preparation and ## Article Body 05/02/2025 | Short News This year, the dialysis center in Sokolov, Czech Republic, celebrates its 40th anniversary. Operating under the Fresenius Medical Care (FME) brand, NephroCare delivers comprehensive care to approximately 100 dialysis patients—from nephrological assessments to the preparation and administration of dialysis. Located in the western Bohemia region, the clinic is one of the largest dialysis centers in the country. Since its founding in 1985, the Sokolov dialysis center has been a pioneer in the treatment of chronic kidney disease in the Czech Republic. From 1986 to 1990, it was the first dialysis center in the former Czechoslovakia to offer respite stays in the Ore Mountains for dialysis patients and their families. In 1997, Fresenius Medical Care (FME), the world’s leading provider of products and services for people with kidney disease, assumed responsibility for the center. “We provide comprehensive care for patients with advanced kidney failure. This includes presenting various treatment options and determining the approach that best aligns with each patient’s health condition and lifestyle,” says Dr. Vlasák, managing director of the dialysis center since 1985. He adds, “We also offer support to patients who choose home dialysis.” Since its inception, the Sokolov dialysis center has prioritized a comfortable environment for its patients. On-site amenities include Wi-Fi access, and patients can receive support from a psychologist or social worker, as well as nutritional counseling. “State-of-the-art equipment is now an integral part of treating chronic kidney failure in Sokolov. We continuously strive to enhance the care we provide to our patients,” says Dana Hrubá, the center’s head nurse. Miroslav Karl, a patient at the Sokolov dialysis center for 33 years, shares, “I’ve been coming to the clinic since January 1992. Over the years, I’ve witnessed remarkable improvements in both the quality and scope of treatment options available. I am deeply grateful to the entire staff, who have not only enabled me to live a normal life but have also allowed me to continue working and enjoy life to its fullest.” Back To top: ## Recent Company News - 2026-07-29 07:00 EST — [Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients](https://biopharmsignal.com/news/FMS/fresenius-medical-care-announces-beacon-us-generating-real-world-evidence-suppor-8547f5f8) — Source: Fresenius Medical Care Ventures - 2026-07-20 07:00 EST — [Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy](https://biopharmsignal.com/news/FMS/fresenius-medical-care-introduces-therapywise-analytics-for-kidney-replacement-t-6fa82f2a) — Source: Fresenius Medical Care Ventures - 2026-06-10 07:00 EST — [Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model](https://biopharmsignal.com/news/FMS/interwell-health-delivers-strong-quality-scores-and-shared-savings-in-cms-value--e2c55e86) — Source: Fresenius Medical Care Ventures - 2026-06-03 07:00 EST — [Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-kinexus-worldwide-a-unified-digital-platform-to-support-home-dialysis) — Source: Fresenius Medical Care Ventures - 2026-05-28 07:00 EST — [Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-first-tranche-of-its-share-buyback-program-of-up-to-eur-600-million) — Source: Fresenius Medical Care Ventures ## Related News - 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627) - 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922) - 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c) - 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec) - 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)